These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2416193)
21. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells. Rhee MS; Galivan J; Wright JE; Rosowsky A Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264 [TBL] [Abstract][Full Text] [Related]
22. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation. Jolivet J; Cole DE; Holcenberg JS; Poplack DG Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094 [TBL] [Abstract][Full Text] [Related]
23. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis. Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783 [TBL] [Abstract][Full Text] [Related]
24. Biological properties of fluoroglutamate-containing analogs of folates and methotrexate with altered capacities to form poly (gamma-glutamate) metabolites. McGuire JJ; Hart BP; Haile WH; Magee KJ; Rhee M; Bolanowska WE; Russell C; Galivan J; Paul B; Coward JK Biochem Pharmacol; 1996 Oct; 52(8):1295-303. PubMed ID: 8937438 [TBL] [Abstract][Full Text] [Related]
25. Characteristics of the accumulation of methotrexate polyglutamate derivatives in Ehrlich ascites tumor cells and isolated rat hepatocytes. Fry DW; Gewirtz DA; Yalowich JC; Goldman ID Adv Exp Med Biol; 1983; 163():215-34. PubMed ID: 6193686 [TBL] [Abstract][Full Text] [Related]
26. The role of folylpolyglutamate synthetase and gamma-glutamyl hydrolase in altering cellular folyl- and antifolylpolyglutamates. Galivan J; Johnson T; Rhee M; McGuire JJ; Priest D; Kesevan V Adv Enzyme Regul; 1987; 26():147-55. PubMed ID: 3499766 [TBL] [Abstract][Full Text] [Related]
27. Enzymatic synthesis of polyglutamate derivatives of 7-hydroxymethotrexate. McGuire JJ; Hsieh P; Bertino JR Biochem Pharmacol; 1984 Apr; 33(8):1355-61. PubMed ID: 6201178 [TBL] [Abstract][Full Text] [Related]
28. Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor. Lack of evidence for influx route-specific effects. Spinella MJ; Brigle KE; Freemantle SJ; Sierra EE; Goldman ID Biochem Pharmacol; 1996 Sep; 52(5):703-12. PubMed ID: 8765468 [TBL] [Abstract][Full Text] [Related]
29. Interaction of methotrexate polyglutamates and dihydrofolate during leucovorin rescue in a human breast cancer cell line (MCF-7). Allegra CJ; Boarman D Cancer Res; 1990 Jun; 50(12):3574-8. PubMed ID: 1692762 [TBL] [Abstract][Full Text] [Related]
30. Folate analog nonsubstrates and inhibitors of folylpolyglutamate synthetase as potential cancer chemotherapy drugs. McGuire JJ; Piper JR; Coward JK; Galivan J NCI Monogr; 1987; (5):139-44. PubMed ID: 2448652 [TBL] [Abstract][Full Text] [Related]
31. gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias. Longo GS; Gorlick R; Tong WP; Lin S; Steinherz P; Bertino JR Oncol Res; 1997; 9(5):259-63. PubMed ID: 9306433 [TBL] [Abstract][Full Text] [Related]
32. Facilitated transport of methotrexate polyglutamates into lysosomes derived from S180 cells. Further characterization and evidence for a simple mobile carrier system with broad specificity for homo- or heteropeptides bearing a C-terminal glutamyl moiety. Barrueco JR; O'Leary DF; Sirotnak FM J Biol Chem; 1992 Oct; 267(28):19986-91. PubMed ID: 1383199 [TBL] [Abstract][Full Text] [Related]
33. Formation of methotrexate polyglutamates in rat hepatocytes. Gewirtz DA; White JC; Randolph JK; Goldman ID Cancer Res; 1979 Aug; 39(8):2914-8. PubMed ID: 455278 [TBL] [Abstract][Full Text] [Related]
34. Synthesis, binding and intracellular retention of methotrexate polyglutamates by cultured human breast cancer cells. Schilsky RL; Jolivet J; Bailey BD; Chabner BA Adv Exp Med Biol; 1983; 163():247-57. PubMed ID: 6193688 [TBL] [Abstract][Full Text] [Related]
35. Methotrexate polyglutamates in cultured human cells. Rosenblatt DS; Whitehead VM Adv Exp Med Biol; 1983; 163():275-85. PubMed ID: 6193690 [TBL] [Abstract][Full Text] [Related]
36. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells. Whitehead VM Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265 [TBL] [Abstract][Full Text] [Related]
37. DL-threo-4-fluoroglutamic acid. A chain-terminating inhibitor of folylpolyglutamate synthesis. McGuire JJ; Coward JK J Biol Chem; 1985 Jun; 260(11):6747-54. PubMed ID: 2860109 [TBL] [Abstract][Full Text] [Related]
38. In vitro methotrexate polyglutamate synthesis by rat liver folylpolyglutamate synthetase and inhibition by bromosulfophthalein. McGuire JJ; Hsieh P; Coward JK; Bertino JR Adv Exp Med Biol; 1983; 163():199-214. PubMed ID: 6193685 [TBL] [Abstract][Full Text] [Related]
39. Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity. Rhee MS; Wang Y; Nair MG; Galivan J Cancer Res; 1993 May; 53(10 Suppl):2227-30. PubMed ID: 7683570 [TBL] [Abstract][Full Text] [Related]